Suven Life Sciences Limited (NSE:SUVEN)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	51,603	24,730	21,742	10,570	13,484	8,961
Market Cap Growth	132.74%	13.74%	105.69%	-21.61%	50.48%	228.97%
Enterprise Value	51,003	23,067	19,870	10,468	13,313	8,934
Last Close Price	235.20	113.67	100.00	48.50	85.42	65.10
PS Ratio	686.53	371.55	185.94	77.75	112.83	63.67
PB Ratio	46.92	22.48	8.05	2.82	14.03	8.30
P/TBV Ratio	46.99	22.52	8.06	2.82	14.06	8.31
EV/Sales Ratio	-	346.57	169.93	77.00	111.40	63.48
Debt / Equity Ratio	-	-	0.00	0.00	0.03	0.04
Asset Turnover	-	0.03	0.04	0.06	0.10	0.09
Inventory Turnover	-	1.59	2.30	27.66	9.10	0.26
Quick Ratio	-	2.62	18.01	21.03	7.13	3.42
Current Ratio	-	3.21	18.99	22.61	8.01	6.45
Return on Equity (ROE)	-	-84.60%	-32.56%	-50.17%	-119.51%	-57.41%
Return on Assets (ROA)	-	-50.94%	-24.91%	-33.21%	-66.72%	-33.54%
Return on Capital (ROIC)	-62.80%	-56.20%	-25.92%	-34.65%	-74.38%	-39.72%
Earnings Yield	-3.57%	-6.50%	-4.83%	-11.19%	-9.05%	-8.05%
FCF Yield	-	-7.74%	-5.31%	-11.25%	-10.93%	-11.42%
Dividend Yield	-	-	-	-	1.17%	-
Buyback Yield / Dilution	-0.29%	-	-22.31%	-32.29%	-5.88%	-
Total Shareholder Return	-	-	-22.31%	-32.29%	-4.71%	-

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.